Cassie joined HGF’s Manchester office in October 2017 as part of the Electronics team, and qualified to become a Chartered Patent Attorney (UK) and a European Patent Attorney in 2021.
Cassie has experience drafting and prosecuting applications across a variety of electronics and computing technologies including computer algorithms, AI, medical technology, security, consumer electronics and autonomous vehicles. She has particular experience in the issues surrounding drafting and prosecuting computer-implemented inventions, and works directly with a wide variety of clients including SMEs and Universities. Cassie has successful experience with EPO Oppositions.
Prior to joining the profession, during her degree and subsequent research Cassie worked on the interface of biology and computing. Her work included stochastic modelling of population dynamics, and engineering solutions to the assessment of dog welfare, exploring the potential to use the entropy of accelerometer signals as a welfare parameter.
MMathPhys in Mathematics and Physics
PGCert in Intellectual Property Law
MRes in Neuroscience
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.